Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort.
Hepatology communications
View this publicationHepatology communications
View this publicationAnnals of surgical oncology
View this publicationAllergy
View this publicationJournal of leukocyte biology
View this publicationCancers
View this publicationScientific reports
View this publicationFrontiers in immunology
View this publicationArchives of Iranian medicine
View this publicationHuman brain mapping
View this publicationImmunology letters
View this publication